LCTX$1.01-0.49%
Lineage Cell Therapeutics, Inc.
Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: NYSE
Mkt Cap:$254.17M
Float & O/S:
Inst Own:
DilutionScan read 32 of Lineage Cell Therapeutics, Inc.'s SEC filings and found 4 warrant series, 2 ATM programs, 3 shelf registrations and 2 completed offerings on file for LCTX. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Oct 31, 2026.
